The medical technology company Sensodetect has terminated a time-limited commercial agreement with Al Masarat by mutual agreement, according to a press release.However, the overall cooperation agreement from September 2024 remains in place, under which Al Masarat continues to act as the commercial agent in the region on a commission-based model. The termination is assessed to have no material financial impact on the company."We are pleased to confirm the continued cooperation with Al Masarat within the framework of our long-term agent agreement. This creates good conditions for the next phase in our commercial development in the region," says Per-Anders Hedin, CEO of Sensodetect.